Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1259-1263

  Awada, Ahmad ^a,b   Nicaise, Charles ^a,c   Ena, Sabrina ^b   Schandéné, Liliane ^a   Rasschaert, Joanne ^b   Popescu, Iuliana ^b   Gangji, Valérie ^a,b   Soyfoo, Muhammad S ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c DIAPATH Center for Microscopy and Molecular Imaging (CMMI)   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 33; PROTEIN ST2; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IN VITRO STUDY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVARY GLAND; SCORING SYSTEM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

AUTOIMMUNITY; CYTOKINES; INFLAMMATION; SJÖGREN'S SYNDROME;

CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; RECEPTORS, CELL SURFACE; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84899946301     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-203187     Document Type: Article

References (17)

1. Fox RI. Sjogren's syndrome. Lancet 2005;366: 321-31.
2. Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nat Rev Rheumatol 2010;6: 529-37.
3. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010;10: 826-37.
4. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23: 479-90. (Pubitemid 41587888)
5. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008;3:e3331.
6. Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol 2011;7: 321-9.
7. Verri WA Jr., Souto FO, Vieira SM, et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010;69: 1697-703.
8. Terras S, Opitz E, Moritz RK, et al. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis 2013;72: 144-5.
9. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61: 554-8. (Pubitemid 34539104)
10. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010;34: 400-7.
11. Chisholm DM. Minor salivary gland pathology in Sjogren's Syndrome and rheumatoid arthritis. Proc Int Acad Oral Pathol 1969: 44-56.
12. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69: 1103-9.
13. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223: 20-38. (Pubitemid 351986169)
14. Oshikawa K, Yanagisawa K, Tominaga S, et al. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002;32: 1520-6. (Pubitemid 35278923)
15. Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010;467: 967-71.
16. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116: 1218-22.
17. Szodoray P, Gal I, Barath S, et al. Immunological alterations in newly diagnosed primary Sjogren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines. Scand J Rheumatol 2008;37: 205-12. (Pubitemid 351874010)